Royal Bank of Canada’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.65M | Sell |
19,000
-23,000
| -55% | -$2.2M | ﹤0.01% | 3238 |
|
|
2025
Q4 | $4.04M | Buy |
+42,000
| New | +$4.08M | ﹤0.01% | 2596 |
|
|
2025
Q1 | – | Sell |
-580,800
| Closed | -$46.4M | – | 7074 |
|
|
2024
Q4 | $46.4M | Buy |
+580,800
| New | +$50.3M | 0.01% | 877 |
|
|
2021
Q1 | – | Sell |
-20,300
| Closed | -$2.38M | – | 7584 |
|
|
2020
Q4 | $2.38M | Buy |
20,300
+12,800
| +171% | +$1.41M | ﹤0.01% | 2768 |
|
|
2020
Q3 | $779K | Buy |
+7,500
| New | +$753K | ﹤0.01% | 3472 |
|
|
2020
Q2 | – | Sell |
-15,700
| Closed | -$1.42M | – | 6787 |
|
|
2020
Q1 | $1.42M | Sell |
15,700
-180,400
| -92% | -$19.2M | ﹤0.01% | 2751 |
|
|
2019
Q4 | $22.2M | Buy |
196,100
+35,800
| +22% | +$3.93M | 0.01% | 1095 |
|
|
2019
Q3 | $17.4M | Sell |
160,300
-100
| -0.1% | -$10.4K | 0.01% | 1172 |
|
|
2019
Q2 | $15.6M | Sell |
160,400
-89,600
| -36% | -$8.18M | 0.01% | 1263 |
|
|
2019
Q1 | $22.8M | Buy |
250,000
+89,600
| +56% | +$8.02M | 0.01% | 980 |
|
|
2018
Q4 | $14.6M | Buy |
+160,400
| New | +$15M | 0.01% | 1191 |
|
|
2018
Q3 | – | Sell |
-25,000
| Closed | -$2.14M | – | 6853 |
|
|
2018
Q2 | $2.14M | Hold |
25,000
| – | – | ﹤0.01% | 2675 |
|
|
2018
Q1 | $2.01M | Sell |
25,000
-435,800
| -95% | -$35.9M | ﹤0.01% | 2683 |
|
|
2017
Q4 | $37.2M | Buy |
+460,800
| New | +$36.9M | 0.02% | 760 |
|
|
2017
Q3 | – | Sell |
-63,500
| Closed | -$5.64M | – | 6860 |
|
|
2017
Q2 | $5.64M | Sell |
63,500
-58,300
| -48% | -$4.92M | ﹤0.01% | 1872 |
|
|
2017
Q1 | $9.81M | Buy |
121,800
+1,800
| +2% | +$141K | 0.01% | 1502 |
|
|
2016
Q4 | $8.55M | Buy |
+120,000
| New | +$9.43M | ﹤0.01% | 1608 |
|
|
2016
Q3 | – | Sell |
-50,000
| Closed | -$4.34M | – | 6503 |
|
|
2016
Q2 | $4.34M | Hold |
50,000
| – | – | ﹤0.01% | 1992 |
|
|
2016
Q1 | $3.75M | Buy |
+50,000
| New | +$3.77M | ﹤0.01% | 2003 |
|
|
2015
Q4 | – | Sell |
-170,000
| Closed | -$11.4M | – | 6756 |
|
|
2015
Q3 | $11.4M | Sell |
170,000
-270,000
| -61% | -$19.9M | 0.01% | 1071 |
|
|
2015
Q2 | $32.6M | Sell |
440,000
-89,600
| -17% | -$6.85M | 0.02% | 572 |
|
|
2015
Q1 | $41.3M | Buy |
+529,600
| New | +$40.1M | 0.03% | 466 |
|
|
2014
Q1 | – | Sell |
-137,500
| Closed | -$7.89M | – | 6043 |
|
|
2013
Q4 | $7.89M | Buy |
137,500
+100,000
| +267% | +$5.67M | 0.01% | 1343 |
|
|
2013
Q3 | $2M | Sell |
37,500
-68,500
| -65% | -$3.69M | ﹤0.01% | 2208 |
|
|
2013
Q2 | $5.46M | Buy |
+106,000
| New | +$5.24M | ﹤0.01% | 1397 |
|
Other funds holding MDT
VCM
VPM
Royal Bank of Canada's MDT Position: Q1 2026 in Review
Royal Bank of Canada increased its Medtronic (MDT) stake by 1.4% in Q1 2026, buying an estimated $18.3M and bringing the position to 14,179,817 shares worth $1.23B. The position accounts for 0.22% of the portfolio, ranked #83.
Royal Bank of Canada first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.54B in Q3 2021. 2,237 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Royal Bank of Canada held 14,179,817 shares of Medtronic worth $1.23B as of Q1 2026.
- Royal Bank of Canada bought 190,987 Medtronic shares in Q1 2026, an estimated $18.3M.
- Medtronic made up 0.22% of Royal Bank of Canada's portfolio in Q1 2026, its #83 holding.
- Royal Bank of Canada first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Medtronic position peaked at $1.54B in Q3 2021.
- 2,237 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.